ISTH 2025 21 - 25 June 2025

FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab

Authors :

Johannes Oldenburg^1*; Gary Benson²; Pratima Chowdary³; Robert Klamroth^4,5; Anne Lienhart⁶; Davide Matino⁷; Camila Martins Mazini Tavares⁸ Keiji Nogami⁹ Flora Peyvandi^10,11; Amalie Rhode Høgh Nielsen⁸; Guy Young¹²; Allison P Wheeler¹³

Affiliations

View Details Hide Details

Keywords

Rare Blood Disorders

Congress oral presentation

Mim8

Search Science Hub

Are you a healthcare professional?

FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab